The Altered Schedule II and the Lapsed DEA Registration
Marcus Bell, PharmD, is the closing pharmacist at a two-pharmacist community pharmacy in Rockford, Illinois. At 8:40 p.m. a 31-year-old man presents a paper prescription for oxycodone 30 mg, quantity 90, 'one tablet by mouth four times daily as needed for pain,' written four days earlier by an Illinois physician whose office is 60 miles away. The quantity field looks altered from 30 to 90 - the '9' is in different ink and a different hand. The patient is new to the pharmacy, is paying cash, and is visibly impatient. Marcus queries the Illinois Prescription Monitoring Program and sees the same patient received 90 oxycodone tablets from two other pharmacies in the past nine days, plus an alprazolam fill. Marcus also checks the prescriber's DEA registration and finds it expired three weeks ago.
1. Identify every independent reason this prescription cannot be filled as presented, and state what Marcus may and may not do to salvage it.
Read the worked answer
Three independent defects, any one of which is disqualifying:
- The document has been altered. A pharmacist may not fill a Schedule II prescription that a patient has altered, and may not 'correct' the quantity by adding to or overwriting it. Accepting a phone clarification to change the quantity on a CII does not cure an alteration - the prescriber must issue a new, unaltered prescription. Marcus may not dispense a 'partial' version of 30 to make it match the original either, because he cannot know what the original said.
- The prescriber was not DEA-registered on the date of issuance. A controlled substance prescription is valid only if issued by a practitioner with a current DEA registration covering that schedule. A prescription that post-dates the registration's expiration is not a valid order, even if the prescriber renews the registration tomorrow. The prescriber may issue a new prescription now that registration is current; that new order would be valid.
- Corresponding responsibility. Under 21 CFR 1306.04(a) the pharmacist shares responsibility for the legitimacy of every controlled substance prescription. Cash payment, a new patient, a 60-mile prescriber distance, an identical recent fill pattern on the PMP, and a concurrent benzodiazepine are classic red flags. Marcus must resolve them with a satisfactory explanation before dispensing, not after.
What he may do: verify the prescriber's registration status directly (DEA registration check, or a call to the office asking for the current DEA number and expiration); document the verification.
What he may not do: alter or annotate the quantity, accept an oral 'correction' for a CII, treat the emergency-oral-CII exception as available (it requires a genuine emergency and a written follow-up prescription within 7 days - neither exists here), or fill on the theory that 'the PMP will catch it.'
2. Assume Marcus refuses to fill. What should he do with the document, what may he say to the patient, and what must he document?
Read the worked answer
The document. He should not confiscate it. A pharmacist may decline to fill and return the original to the patient; keeping it is permissible only if pharmacy policy and local practice support it, and even then the patient must be told where it is and how to get it back. If he suspects forgery he may contact law enforcement, but he is not obligated to detain the patient or the paper.
What he may say. A short, non-accusatory statement: 'I'm not able to fill this as written - you'll need to contact your prescriber.' He should not lecture, accuse the patient of forgery, or disclose PMP contents to the patient as the reason. Refusal must be based on the prescription and the clinical/legal analysis, never on a protected characteristic or on the patient's payment method alone. He may offer to call the prescriber on the patient's behalf.
What he must document. A contemporaneous note in the pharmacy's records: date and time; patient identifiers; prescriber name and DEA number; drug, strength, quantity, and directions as presented; the specific deficiencies (alteration, lapsed registration, PMP findings); the verification attempts made and their outcomes, including who he spoke with; the decision and the reason; and his name and license number. Retain it for the period required by Illinois recordkeeping rules - verify the Illinois retention period, but note the federal floor for controlled substance records is two years.
He should also consider a professional courtesy call to the prescriber, who may be unaware that a patient is presenting altered prescriptions under his name. That call is voluntary, not a legal duty.
3. What, if anything, should Marcus do about the two prior fills and the expired prescriber registration?
Read the worked answer
The prior fills. He is not the dispensing pharmacy for those prescriptions, so he cannot reverse them and should not attempt to. What he can do is decline to add a third source, document his PMP review, and - if he concludes the pattern is diversion - notify the prescribers involved and, if he believes a prescription was forged, report it to local law enforcement. There is no PMP 'flag' function a pharmacist can set; his leverage is refusal plus communication.
The registration. Marcus should distinguish two questions: (a) Is the prescriber registered now? - checkable and often yes, since lapses are frequently administrative; and (b) Was the prescriber registered when this prescription was written? - if no, the order is invalid regardless of current status. A renewal today does not retroactively validate a prescription written during the lapse; the prescriber must write a new one.
Practical drafting point. If the prescriber's office insists the prescription is fine, Marcus should ask them to fax or e-prescribe a clean, newly dated prescription with a current DEA number, then re-run the red-flag analysis from scratch. A clean document does not erase the PMP pattern - the corresponding-responsibility inquiry still has to be answered.